These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1659164)

  • 1. Novel strategies for the selection of cells expressing human adenosine deaminase and their application in experimental gene therapy protocols.
    Shen Q; Van Beusechem VW; Hendrikx PJ; Valerio D
    Allergol Immunopathol (Madr); 1991; 19(1):29-31. PubMed ID: 1659164
    [No Abstract]   [Full Text] [Related]  

  • 2. Retroviral-mediated gene transfer into mammalian cells.
    Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
    Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for X-linked immunodeficiencies.
    Kinnon C; O'Reilly MA; Pelham A; Malcolm S; Porter CD; Parkar MH; Collins MK; Leveinsky RJ
    Allergol Immunopathol (Madr); 1991; 19(1):32-7. PubMed ID: 1683141
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospects for gene therapy of human disease.
    Blaese RM; Culver KW
    Allergol Immunopathol (Madr); 1991; 19(1):25-8. PubMed ID: 1683140
    [No Abstract]   [Full Text] [Related]  

  • 5. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
    Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
    Belmont JW; Henkel-Tigges J; Chang SM; Wager-Smith K; Kellems RE; Dick JE; Magli MC; Phillips RA; Bernstein A; Caskey CT
    Nature; 1986 Jul 24-30; 322(6077):385-7. PubMed ID: 3016551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic cell gene therapy: the model of adenosine deaminase deficiency.
    Van Beusechem VW; Kukler A; Bakx TA; Valerio D
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():133-6. PubMed ID: 2697426
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.
    Culver KW; Osborne WR; Miller AD; Fleisher TA; Berger M; Anderson WF; Blaese RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):170-1. PubMed ID: 1846711
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
    Kaplitt MG; Leone P; Samulski RJ; Xiao X; Pfaff DW; O'Malley KL; During MJ
    Nat Genet; 1994 Oct; 8(2):148-54. PubMed ID: 7842013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer and expression of human ADA in murine hematopoietic stem cells.
    Williams DA; Lim B; Orkin SH
    Prog Clin Biol Res; 1987; 251():567-80. PubMed ID: 3432278
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression vectors for human adenosine deaminase gene therapy.
    Moore KA; Fletcher FA; Alford RL; Villalon DK; Hawkins DH; MacGregor GR; Caskey CT; Belmont JW
    Genome; 1989; 31(2):832-9. PubMed ID: 2576653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy of primary immunodeficiencies.
    Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects for gene therapy for immunodeficiency diseases.
    Kantoff PW; Freeman SM; Anderson WF
    Annu Rev Immunol; 1988; 6():581-94. PubMed ID: 3289578
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficient transfection of novel bovine papillomavirus 1 expression plasmids.
    Lampela P; Ustav E; Ustav M; Niskanen M; Männistö PT; Raasmaja A
    Plasmid; 2001 Nov; 46(3):163-9. PubMed ID: 11735366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer into humans: a first step.
    Cournoyer D; Caskey CT
    N Engl J Med; 1990 Aug; 323(9):601-3. PubMed ID: 2381445
    [No Abstract]   [Full Text] [Related]  

  • 16. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
    Pan D; Aronovich E; McIvor RS; Whitley CB
    Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase deficiency.
    Hirschhorn R
    Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental bias in the evaluation of the cellular transient expression in DNA co-transfection experiments.
    Bergeron D; Barbeau B; Léger C; Rassart E
    Cell Mol Biol Res; 1995; 41(3):155-9. PubMed ID: 8589755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord blood stem cells as targets for genetic modification: new therapeutic approaches to somatic gene therapy.
    Williams DA; Moritz T
    Blood Cells; 1994; 20(2-3):504-15; discussion 515-6. PubMed ID: 7749118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells.
    Chertkov JL; Jiang S; Lutton JD; Harrison J; Levere RD; Tiefenthaler M; Abraham NG
    Stem Cells; 1993 May; 11(3):218-27. PubMed ID: 8318909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.